Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony@Pacific who wrote (50590)	1/24/2000 10:33:00 PM
From: Montecristo No.2	Read Replies (1) of 122087

Dear A@P: Would you make an exception and venture a target price on VASO? This one may have fewer variables (not counting price momentum of course). It appears that the company has no direct competitors and a patent valid until 2005. We have specific Medicare reimbursement rates and population statistics. Is it not possible to arrive at a potential target based on fundamentals for this company? This is of course assuming that someone else does not come up with an alternative system to deliver EECP circumventing VASO's patents, since the therapy itself is public domain. Would appreciate your input. Thanks

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next